1.Liaw YF, Leung N, Guan R, Lau GK, Merican I, McCaughan G, et at.

Asian-Pacific
consensus statement on the management of chronichepatitis B: a 2005 update. Liver Int
2005;25(3):472-89.
2. Yim HY, Lok Anna SF (2006). Natural history of chronic hepatitis B virusinfection: what
we knew in 1981 and what we know in 2005. Hepatology 43 S173 - S181.
3. Hsu YS, Chien RN, Yeh CT. Long-term outcome after spontaneous HBeAg seroconversion
in patients with chronic hepatitis B. Hepatology.
4. Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, et al. Risk of hepatocellulai carcinoma
across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006,295(1):65-73.
5. Kao JH. Hepatitis B viral genotypes: clinical relevance and molecular characteristics J
Gastroenterol hepatol; 17:643-650.
6. Prevention of Hepatitis A Through Active or Passive Immunization: Recommendation: of
the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Morta Wkly Rep
1999;48 (RR 12):1-38.
7. Gerlich WH, Thomnssen R. Quantitative assays for hepatitis B virus DNA standardization
and quality control. Viral Hep Rev 1995;1:53-57
8. Hawkins A, Davidson F, Simmonds P. Comparison of plasma virus loads amon individuals
infected with hepatitis C virus (HCV) genotypes 1, 2, and 3 by quantiplex HCV RN A assay
versions 1 and 2, Roche Monitor assay, and an in-house limitin dilution method. J Clin
Microbiol 1997;35(1):187-92.
9.Hepatitis B, Fact sheet No.328, May 2008
10. Departemen Kesehatan RI Direktorat Jendral Pemberantasan Penyakit Menular dan
Penyehatan

Lingkungan

Tahun

2004.Peraturan

Mentri

Kesehatan

RI

no.949/MENKES/SK/VIII/2004 tentang Pedoman Penyelenggaraan Sistem Kewaspadaan

Dini Kejadian Luar Biasa (KLB)
11. Departemen Kesehatan RI Direktorat Jendral Pemberantasan Penyakit Menular dan
Penyehatan

Lingkungan

Tahun

2004.Peraturan

Mentri

Kesehatan

RI

no.1479/MENKES/SK/X/ 2003 tentang Pedoman Penyelenggaraan Surveilans Epidemiologi

Penyakit Menular dan Penyakit tidak menular.